Quantcast
Connect with us

Ex-hedge funder buys rights to AIDS drug and raises price from $13.50 to $750 per pill

Published

on

A former hedge fund manager turned pharmaceutical businessman has purchased the rights to a 62-year-old drug used for treating life-threatening parasitic infections and raised the price overnight from $13.50 per tablet to $750.

WATCH: Ex-hedge funder who hiked AIDS pill cost by 5,500 percent says drug ‘still underpriced’

According to the New York Times, Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim for $55 million on the same day that Turing announced it had raised $90 million from Shkreli and other investors in its first round of financing.

ADVERTISEMENT

RELATED: These 37 tweets show how the pharma CEO gouging AIDS patients is even worse than you think

Daraprim is used for treating toxoplasmosis — an opportunistic parasitic infection that can cause serious or even life-threatening problems in babies and for people with compromised immune systems like AIDS patients and certain cancer patients — that sold for slightly over $1 a tablet several years ago.  Prices have increased as the rights to the drug have been passed from one pharmaceutical company to the next, but nothing like the almost 5,500 percent increase since Shkreli acquired it.

Worrying that the cost of treatment could devastate some patients, Dr. Judith Aberg, the chief of the division of infectious diseases at the Icahn School of Medicine at Mount Sinai asked, “What is it that they are doing differently that has led to this dramatic increase?”

According to Shkreli, Turing will use the money it earns to develop better treatments for toxoplasmosis, with fewer side effects.

“This isn’t the greedy drug company trying to gouge patients, it is us trying to stay in business,” Shkreli explained, saying that many patients use the drug for far less than a year and that the new price is similar to other drugs used for rare diseases.

ADVERTISEMENT

Shrkeli also defended his small pharmaceutical company saying, “It really doesn’t make sense to get any criticism for this.”

This is not the first time the fledgling pharmaceutical executive has come under scrutiny.

He started the hedge fund MSMB Capital while in his 20’s and was accused of urging the FDA to not approve certain drugs made by companies whose stock he was shorting.

ADVERTISEMENT

In 2011,  Shkreli helped form Retrophin, which also acquired old drugs and immediately raised their prices. Retrophin’s board fired Shkreli a year ago and has filed a complaint in Federal District Court, accusing him of using Retrophin as a personal fund to pay back angry investors in his hedge fund.

 As for Shrkeli’s claim that he will put the excess profits back into research, doctors say that isn’t needed in this case.

ADVERTISEMENT

“I certainly don’t think this is one of those diseases where we have been clamoring for better therapies,” said Dr. Wendy Armstrong, professor of infectious diseases at Emory University in Atlanta.

Tweet from Martin Shkreli’s Twitter account below:

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump ripped by former Ted Cruz aide for his ‘firehose of falsehoods’ as we ‘tally the sick and the dead’

Published

on

In a column for the conservative Bulwark, a former speechwriter and aide to Sen. Ted Cruz (R-TX) expressed her disgust with Donald Trump for his continuing lying about the seriousness of the coronavirus pandemic while at the same time bragging about the TV ratings for his daily press conferences.

According to Amanda Carpenter, who also doubles as a conservative commentator on CNN, she has had it with his "firehose of falsehoods' " and "avalanche of lies" while the country is reeling from a health crisis that has trapped almost 80 percent of the populace in their homes.

Continue Reading

Breaking Banner

‘Fox News is eating her brain’: Columnist describes drastic measures to get her mom to take COVID-19 seriously

Published

on

New York Times columnist Kara Swisher had an incredibly hard time getting her mother to take the threat of COVID-19 seriously -- and she says that Fox News is primarily to blame.

In her latest column, Swisher said that her mother for the past few weeks largely kept going about her daily life as though there weren't a deadly pandemic raging across the country. Swisher became so concerned for her mother's safety that she frantically called and texted her to the point where her mother told her to knock it off.

Continue Reading
 

Breaking Banner

Florida Democrats beg Gov. Ron DeSantis to ignore the White House and issue stay-at-home order

Published

on

More than a dozen Florida lawmakers called on Gov. Ron DeSantis to lock down the state to slow the spread of the deadly coronavirus.

White House medical adviser Dr. Anthony Fauci has warned Americans that social distancing must continue for at least several more weeks to space out the number of cases so patients don't overwhelm hospitals, and 13 Democratic lawmakers asked DeSantis to issue a stay-at-home order, reported WFLA-TV.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image